Cirugía, Ciencias Médicas y Sociales
Departamento
Novartis (Sweden)
Täby, SueciaPublications in collaboration with researchers from Novartis (Sweden) (8)
2023
2022
-
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD
Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 260, Núm. 6, pp. 1843-1856
2021
-
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design
Future Oncology, Vol. 17, Núm. 12, pp. 1459-1472
2020
-
RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Results From LUMINOUS, a Global Real-World Study
Retina (Philadelphia, Pa.), Vol. 40, Núm. 9, pp. 1673-1685
-
Reply
Retina (Philadelphia, Pa.)
2017
-
Evaluation of a community-based hypertension improvement program (ComHIP) in Ghana: data from a baseline survey
BMC Public Health, Vol. 17, Núm. 1
2013
-
Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme
British Journal of Ophthalmology, Vol. 97, Núm. 9, pp. 1161-1167
2011
-
Why a Bayesian approach to safety analysis in pharmacovigilance is important
Pharmaceutical Statistics, Vol. 10, Núm. 6, pp. 554-559